G-DOC: a systems medicine platform for personalized oncology

Area of Science:

• Bioinformatics
• Systems Biology
• Cancer Research

Background:

• Current cancer therapy often uses a "one-size-fits-all" approach, neglecting individual tumor biology.
• Developing personalized cancer treatments is challenging due to limited, disparate high-quality omics data.
• Integrating diverse biomedical data is crucial for translating research findings into clinical practice.

Purpose of the Study:

• To introduce the Georgetown Database of Cancer (G-DOC), a unified web platform for cancer research.
• To enable the integration of patient data with multi-omics datasets and bioinformatics tools.
• To facilitate the development of patient-specific cancer treatments.

Main Methods:

• G-DOC integrates patient characteristics and clinical outcomes with high-throughput omics data (DNA, mRNA, microRNA, metabolites).
• The platform provides a unified environment for analyzing and visualizing data from over 2500 breast and 800 gastrointestinal cancer patients.
• It incorporates a suite of bioinformatics and systems biology tools for data analysis.

Main Results:

• G-DOC successfully integrates diverse data types from a substantial patient cohort.
• The platform supports the analysis of multiple omics layers, including DNA, mRNA, microRNA, and metabolites.
• Representative usage scenarios demonstrate the platform's utility in identifying trends and patterns.

Conclusions:

• G-DOC facilitates systems medicine by enabling integrated data analysis.
• The platform supports the identification of unique tumor signatures for targeted cancer therapies.
• G-DOC is a valuable resource for advancing personalized medicine in oncology.